Kitazato

Kitazato FCF Growth

The Year-over-Year Free Cash Flow Growth of Kitazato (368A.T) as of Nov 17, 2026 is -40.60 %. In the previous year, Year-over-Year Free Cash Flow Growth was 115.41 % — a change of -135.18% (lower).

FCF Growth

-40.60 %

YoY

-135.18%

Last updated:

Year-over-Year Free Cash Flow Growth of Kitazato is 2025 -40.60 % . Year-over-Year Free Cash Flow Growth of Kitazato was 2024 115.41 % . It decreases by -135.18% lower compared to the previous year.

The Kitazato FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2024
115.41 JPY
Jan 1, 2025
-40.60 JPY
The Kitazato FCF Growth history
YEARFCF GrowthYoY
-40.60 %-135.18%
115.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Year-over-Year Free Cash Flow Growth of Kitazato is -40.60 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Kitazato since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Kitazato historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Kitazato

All Key Metrics — Kitazato